ADM, PPFIA4, and TPBG exhibited greater expression levels in the CAD group than in the control group, but FAM162A showed lower expression levels in the CAD group, when we compared the expression of these genes between CAD and control samples in the GSE113079 dataset (Figure 4A). The gene discussed is FAM162A; the disease is coronary artery disorder.